Postherpetic polyneuropathy
ICD-10 B33.3 is a billable code used to indicate a diagnosis of postherpetic polyneuropathy.
Postherpetic polyneuropathy is a complication that arises following an outbreak of herpes zoster (shingles), which is caused by the reactivation of the varicella-zoster virus (VZV). This condition is characterized by persistent neuropathic pain and sensory disturbances that can occur in the area previously affected by the herpes zoster rash. The pain can be debilitating and may last for months or even years after the initial infection has resolved. Patients often report symptoms such as burning, tingling, and allodynia, where normally non-painful stimuli cause pain. Diagnosis is primarily clinical, based on the patient's history of shingles and the presence of neuropathic pain. Diagnostic methods may include nerve conduction studies and electromyography to assess the extent of nerve damage. Antiviral treatments, such as acyclovir, valacyclovir, or famciclovir, are most effective when administered early in the course of herpes zoster. However, their efficacy in preventing postherpetic polyneuropathy is limited. Management of postherpetic pain may involve analgesics, anticonvulsants, or antidepressants, which can help alleviate symptoms and improve quality of life.
Detailed history of neurological symptoms, prior herpes zoster infection, and results from nerve conduction studies.
Patients presenting with chronic pain following shingles, requiring assessment for neuropathic pain management.
Neurologists should ensure comprehensive documentation of symptomatology and treatment response.
Thorough documentation of pain characteristics, treatment history, and response to therapies.
Management of chronic pain in patients with a history of herpes zoster.
Pain management specialists should document the multidisciplinary approach to treatment.
Used for pain management in patients with postherpetic polyneuropathy.
Document the specific nerve targeted and the patient's response to previous treatments.
Pain management specialists should ensure that the injection is justified based on the patient's pain history.
Postherpetic polyneuropathy is primarily caused by the reactivation of the varicella-zoster virus, which leads to nerve damage and persistent pain following a shingles outbreak.
